Replication Medical, Inc.

by Sharon O'Reilly Once considered the high flying segment of the musculoskeletal industry, blessed with decade long double-digit growth rates outpacing many of the traditional orthopedic markets, the

by Sharon O'Reilly Injectable products that can alleviate pain and even reverse the disease process are on the horizon for treating degenerative orthopedic and spinal conditions, such as damaged artic

by Sharon O’Reilly As robust and innovative as ever, the market for spinal implants and instruments grew by more than 17% last year and now exceeds $6 billion in worldwide revenues. While products for

Sparing the Rod and Growing the Market Arthroplasty of the spine, the replacement of a disc or nucleus in an effort to repair damaged vertebrae, will be, according to several companies that each spent